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Antiradical activity and antioxidant properties of a conjugate of Xymedon with L-ascorbic 
acid were studied. In contrast to Xymedon, a conjugate of Xymedon with L-ascorbic acid was 
found to react with free radicals. Pro-oxidant activity of the conjugate of Xymedon with L-
ascorbic acid in a chemiluminescence system is weaker as compared to individual L-ascorbic 
acid. This is the evidence of the increase in the stability of ascorbic acid upon conjugation with 
a molecule of Xymedon. Conjugate of Xymedon with L-ascorbic acid facilitates the decrease in 
the concentration of a lipid peroxidation product (malondialdehyde) and the activity of super-
oxide dismutase in liver and serum of laboratory animals exposed to intoxication with a known 
hepatotropic toxin CCl4. This observation shows the contribution of the antioxidant action to 
the hepatoprotective eff ect of the studied Xymedon derivative.
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Pyrimidine derivatives attract attention due to their 
ability to stimulate tissue regeneration. Among them, 
Xymedon (1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydro-
pyrimidine-2-one) is a known medicine with considerable 
regenerative and reparative properties,1 which is success-
fully used in clinical practice for treatment of burn wounds 
and other pathological states, as well as in the post-oper-
ative period.2—5 In our earlier studies,6,7 we revealed 
hepatoprotective activity of Xymedon, and, in particular, 
the decrease in pathomorphological changes in liver and 
normalization of biochemical markers of liver disease. 
Xymedon
In recent publications,8—10 chemical modiﬁ cation of 
therapeutic drugs, and conjugation in particular, is re-
garded as a way to increase their bioavailability and effi  -
ciency. Earlier, in our publication11 we reported the syn-
thesis of Xymedon complexes 1a—e with biogenic acids, 
namely, succinic, ascorbic, p-aminobenzoic, nicotinic, and 
L-2-amino-4-(methylthio)butanoic (L-methionine) acids.
These biogenic acids were chosen for preparation of 
Xymedon complexes 1a—e since they are common me-
*  Based on the materials of III Interdisciplinary Symposium 
on Medicinal, Organic, and Biological Chemistry and Pharma-
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